First Trust Advisors LP Supernus Pharmaceuticals, Inc. Transaction History
First Trust Advisors LP
- $101 Billion
- Q3 2024
A detailed history of First Trust Advisors LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 52,067 shares of SUPN stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,067
Previous 21,493
142.25%
Holding current value
$1.97 Million
Previous $574,000
182.75%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding SUPN
# of Institutions
283Shares Held
60.8MCall Options Held
27.7KPut Options Held
11.3K-
Black Rock Inc. New York, NY10.4MShares$394 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.13MShares$232 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.1MShares$193 Million2.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$109 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$99.7 Million0.09% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.03B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...